Albert A. Prast - 10 Aug 2023 Form 4 Insider Report for AdaptHealth Corp. (AHCO)

Signature
/s/ Shannone Raybon, as attorney-in-fact for Albert Prast***
Issuer symbol
AHCO
Transactions as of
10 Aug 2023
Net transactions value
-$2,298,179
Form type
4
Filing time
14 Aug 2023, 18:59:38 UTC
Previous filing
13 Mar 2023
Next filing
13 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AHCO Common Stock Options Exercise $538,000 +200,000 +181% $2.69* 310,578 10 Aug 2023 Direct
transaction AHCO Common Stock Sale $2,753,100 -194,428 -63% $14.16 116,150 10 Aug 2023 Direct F1
transaction AHCO Common Stock Sale $83,079 -5,572 -4.8% $14.91 110,578 10 Aug 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AHCO Employee Stock Option (right to buy) Options Exercise $0 -200,000 -60% $0.000000 135,443 10 Aug 2023 Common Stock 200,000 $2.69 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.835 to $14.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.835 to $14.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Remarks:

Exhibit 24 - Power of Attorney